Lion Point Capital »

Seres Therapeutics shares owned by Lion Point Capital

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $477k 341k 1.40
2023-09-30 $1.6M 692k 2.38
2023-06-30 $3.3M 692k 4.79
2023-03-31 $3.4M 597k 5.67
2022-12-31 $3.1M 597k 5.21
2022-09-30 $3.2M 627k 5.15
2022-06-30 $2.7M 482k 5.53
2022-03-31 $3.4M 482k 7.12
2021-12-31 $4.0M 482k 8.33
2021-09-30 $3.4M 482k 6.96